PodoMedic
ActiveSummary
PodoMedic has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €4,874 and a net result of €102,534. Equity is shrinking by about 47% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2026. Its solvency ranks better than 6% of 20,614 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
25-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 25 days late
2025
31-12
Financial
Highest result from 2023 to 2025net €102,534 ▲51.7%
Operating result €131,045, net result €102,534, both a record.
29-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 29 days late
2024
31-12
Financial
Equity above €150,000equity €152,340 ▲79.7%
A profit in every financial year since 2023 builds equity to €152,340.
28-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 28 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.